AlphaStocks
7.9
Strong Buy

Innoviva, Inc. (INVA)

Health Care / Pharmaceuticals

S&P SmallCap 600

$23.42

Above average across most dimensions. A solid candidate.

Strong Buy

Score based on 4 of 5 models — moderate confidence

#11out of 1127 in Health Care

Is Innoviva, Inc. a Good Investment in 2026?

Innoviva, Inc. (INVA) scores 7.9 out of 10 on AlphaStocks' composite model, earning a Strong Buy rating. The Lynch model rates Innoviva, Inc. as Strong. The Graham model is the least favorable, rating it Attractive. Innoviva, Inc. ranks #11 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E7.3ROE24.8Market Cap2B

Valuation

Trades at 7x earnings — near sector median of 25x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Attractive

28% below fair value

Lynch

Strong

Growth rate vs price (PEG)

Greenblatt

Strong

Top half (rank 39%)

Frequently Asked Questions

Is Innoviva, Inc. (INVA) a good investment?
Based on AlphaStocks' composite analysis, Innoviva, Inc. (INVA) scores 7.9 out of 10, earning a Strong Buy rating. This places it above average across most investment dimensions. Trades at 7x earnings — near sector median of 25x.
What is Innoviva, Inc.'s Piotroski F-Score?
Innoviva, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is INVA overvalued or undervalued?
A precise fair value estimate is not available for INVA. Trades at 7x earnings — near sector median of 25x.
How does INVA compare to other Health Care stocks?
Innoviva, Inc. ranks #11 out of 1127 stocks in the Health Care sector, placing it in the top 1% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about INVA?
AlphaStocks evaluates INVA using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Attractive; Lynch: Strong; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 7.9/10.

Similar Stocks

PARRFTIAZN

Compare INVA with

INVA vs PARRINVA vs FTIINVA vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer